CORV News and Press, Correvio Pharma Corp. From 08/14/19

Correvio Pharma Corp. (CORV) Q2 2019 Earnings Conference Call August 14, 2019 08:30 AM ET Company Participants Justin Renz - CFO Mark Corrigan - CEO David Dean - Chief Business Development Officer Conference Call Participants David Martin - Bloom Burton Swayampakula Ramak...

Correvio Pharma ( CORV ) Q2 results : Revenues: $7.4M (+19.4%). More news on: Correvio Pharma Corp., Healthcare stocks news, Earnings news and commentary, , Read more ...

Correvio Pharma (NASDAQ: CORV ): Q2 GAAP EPS of -$0.26 misses by $0.05 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...

Correvio Reports Second Quarter 2019 Financial Results Canada NewsWire VANCOUVER, Aug. 14, 2019 FDA Accepts New Drug Application for Brinavess TM ; PDUFA Date Set for December 24, 2019 Recently Strengthened Balance Sheet Extends Cash Runway Into Mid-2020 Man...

NASDAQ: CORV   TSX: CORV VANCOUVER , Aug. 12, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that an abstract highlighting the results of the SPECTRUM study e...

Correvio to Report Second Quarter 2019 Financial Results Canada NewsWire VANCOUVER, Aug. 8, 2019 NASDAQ: CORV  TSX: CORV Conference Call Scheduled for Wednesday, August 14, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) VANCOUVER , Aug. 8, 2019 /CNW/ - Corr...

NASDAQ: CORV   TSX: CORV VANCOUVER , Aug. 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced the closing of its previously announced underwritten public offeri...

Glu Mobile (NASDAQ: GLUU )  -29%  on Q2 earnings . More news on: Glu Mobile Inc., Obalon Therapeutics, Inc., Workhorse Group Inc., Stocks on the move, Read more ...

Correvio Announces Pricing Of Public Offering Of Common Shares Canada NewsWire VANCOUVER, Aug. 2, 2019 NASDAQ: CORV   TSX: CORV VANCOUVER , Aug. 2, 2019 /CNW/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), a specialty pharmaceutical company focused on c...

NASDAQ: CORV   TSX: CORV VANCOUVER , Aug. 1, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has undertaken an overnight marketed underwritten public o...